COVID-19 vaccines
More good news on the vaccine front today, as U.S.-based Moderna, Inc. (Nasdaq: MRNA) says its coronavirus vaccine appears to be 94.5% effective. This announcement follows last week's good news.
More good news on the vaccine front today, as U.S.-based Moderna, Inc. (Nasdaq: MRNA) says its coronavirus vaccine appears to be 94.5% effective. This announcement follows last week's good news.